Hep C Cure Aside, Some Patients Still Benefit From Liver Cancer Screening
(MedPage Today) -- Hepatocellular carcinoma (HCC) risk declined but remained high enough for screening in the first 7 years for some patients cured of their hepatitis C virus infections with direct-acting antivirals, an observational study showed...
Read more »